|
ZNF143 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.144700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.183300E-04 |
| Normal-vs-Stage2 |
3.278200E-01 |
| Normal-vs-Stage3 |
2.373800E-01 |
| Normal-vs-Stage4 |
6.295800E-01 |
| Stage1-vs-Stage2 |
3.680800E-01 |
| Stage1-vs-Stage3 |
3.275800E-01 |
| Stage1-vs-Stage4 |
4.028800E-01 |
| Stage2-vs-Stage3 |
9.588800E-01 |
| Stage2-vs-Stage4 |
8.626600E-01 |
| Stage3-vs-Stage4 |
8.234200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.997500E-03 |
| Normal-vs-AfricanAmerican |
1.914080E-02 |
| Normal-vs-Asian |
9.957900E-02 |
| Caucasian-vs-AfricanAmerican |
9.468800E-01 |
| Caucasian-vs-Asian |
9.103000E-01 |
| AfricanAmerican-vs-Asian |
9.234800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.53780000000148E-05 |
| Normal-vs-Female |
9.804200E-01 |
| Male-vs-Female |
3.061700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.628150E-02 |
| Normal-vs-Extreme_Weight |
1.475020E-03 |
| Normal-vs-Obese |
1.356200E-01 |
| Normal-vs-Extreme_Obese |
1.209590E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.105200E-01 |
| Normal_Weight-vs-Obese |
3.105000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.364200E-01 |
| Extreme_Weight-vs-Obese |
1.567650E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.194000E-01 |
| Obese-vs-Extreme_Obese |
1.094750E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.921000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.316000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.59849999999251E-05 |
| Normal-vs-Age(81-100Yrs) |
3.282000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.960800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.445800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.254390E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.119800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.006100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.492600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.783200E-03 |
| Normal-VS-Type2 PRCC |
2.21870000000068E-05 |
| Normal-VS-KIRP CIMP |
5.508600E-01 |
| Normal-VS-Unclassified PRCC |
3.310200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.959700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.177960E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.916600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.542100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.880300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.061400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.194740E-04 |
| Normal-vs-N1 |
2.946800E-01 |
| Normal-vs-N2 |
1.298030E-01 |
| N0-vs-N1 |
1.283280E-03 |
| N0-vs-N2 |
6.568600E-01 |
| N1-vs-N2 |
2.267000E-01 |
|
|
